BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 2972690)

  • 1. Treatment of Stage A1 prostate cancer.
    Finkbeiner AE; Aktinson WE; Haynes WD; Johnston DE; Ross SW
    J Ark Med Soc; 1988 Oct; 85(5):223-4. PubMed ID: 2972690
    [No Abstract]   [Full Text] [Related]  

  • 2. Adenocarcinoma of the prostate in Iceland: a population-based study of stage, Gleason grade, treatment and long-term survival in males diagnosed between 1983 and 1987.
    Jonsson E; Sigbjarnarson HP; Tomasson J; Benediktsdottir KR; Tryggvadottir L; Hrafnkelsson J; Olafsdottir EJ; Tulinius H; Jonasson JG
    Scand J Urol Nephrol; 2006; 40(4):265-71. PubMed ID: 16916765
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Clinical analysis of 169 patients with prostate cancer].
    Okaneya T; Mizusawa H; Yoneyama T; Taguchi I; Komiyama I; Kawakami M; Hosaka K; Tsuruta T; Murata Y; Komatsu H; Misawa K; Kiyokawa H
    Hinyokika Kiyo; 1996 Aug; 42(8):563-7. PubMed ID: 8889563
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Complex treatment of prostate cancer patients].
    Sviridova TV; Dunchik VN; Mardynskiĭ IuS; Tsodikova LB
    Urol Nefrol (Mosk); 1984; (2):9-13. PubMed ID: 6719653
    [No Abstract]   [Full Text] [Related]  

  • 5. Early outcomes of active surveillance for localized prostate cancer.
    Hardie C; Parker C; Norman A; Eeles R; Horwich A; Huddart R; Dearnaley D
    BJU Int; 2005 May; 95(7):956-60. PubMed ID: 15839912
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adenocarcinoma of the prostate.
    Swanson JO
    J Insur Med; 1997; 29(3):195-203. PubMed ID: 10176369
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical characteristics and primary treatment of prostate cancer in Sweden between 1996 and 2005.
    Adolfsson J; Garmo H; Varenhorst E; Ahlgren G; Ahlstrand C; Andrén O; Bill-Axelson A; Bratt O; Damber JE; Hellström K; Hellström M; Holmberg E; Holmberg L; Hugosson J; Johansson JE; Petterson B; Törnblom M; Widmark A; Stattin P
    Scand J Urol Nephrol; 2007; 41(6):456-77. PubMed ID: 17934985
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Prognosis in stage a prostate cancer].
    Murase T; Kuriyama M; Maeda S; Ando Y; Itoh H; Watanabe H
    Hinyokika Kiyo; 1996 Sep; 42(9):639-43. PubMed ID: 8918661
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Histopathologic changes due to combination of androgen deprivation and transurethral microwave thermotherapy in patients with localized prostate cancer].
    Suzuki R; Jujo Y; Koshiba K; Hoshiai O; Endo T; Aihara M; Nakajo H; Ohori M
    Hinyokika Kiyo; 2009 Feb; 55(2):79-85. PubMed ID: 19301612
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Clinical study of stage a prostatic cancer detected incidentally by transurethral resection of the prostate].
    Nakanishi S; Gotou T; Sawada A; Shibasaki N; Ishitoya T; Okumura K
    Hinyokika Kiyo; 2009 Jan; 55(1):5-8. PubMed ID: 19227204
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Cancer of the prostate with predominant lymphatic manifestation. Apropos of 2 cases].
    Herer B; Waligora J; Delfraissy JF; Dormont J
    J Urol (Paris); 1987; 93(8):475-7. PubMed ID: 3440840
    [TBL] [Abstract][Full Text] [Related]  

  • 12. More about prostate cancer--expectant management versus treatment.
    Lucey DT
    N C Med J; 1999; 60(6):314. PubMed ID: 10581935
    [No Abstract]   [Full Text] [Related]  

  • 13. Adjuvant immunotherapy (BCG) in stage D prostate cancer.
    Guinan PD; John T; Baumgartner G; Sundar B; Ablin RJ
    Am J Clin Oncol; 1982 Feb; 5(1):65-8. PubMed ID: 7081139
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Are monotherapy options reasonable for T3 prostate cancer?
    Schellhammer PF; Lynch DF
    Semin Urol Oncol; 1997 Nov; 15(4):207-14. PubMed ID: 9421447
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adenocarcinoma of the prostate.
    Stallings JW; Atkinson WE; Haynes WD; Kumpuris D; Prather JL; Tranum WL
    J Ark Med Soc; 1988 Feb; 84(9):379-80. PubMed ID: 2964441
    [No Abstract]   [Full Text] [Related]  

  • 16. Editorial comment on: predicting the probability of deferred radical treatment for localised prostate cancer managed by active surveillance.
    Adolfsson J
    Eur Urol; 2008 Dec; 54(6):1304-5. PubMed ID: 18342429
    [No Abstract]   [Full Text] [Related]  

  • 17. Management of stage T1b (A2) and stage T1c adenocarcinoma of the prostate.
    Konety BR; Bahnson RR
    Semin Urol Oncol; 1996 Aug; 14(3):183-94. PubMed ID: 8865482
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prostatic cancer in patients 80 years of age.
    Pow-Sang J; Ramirez G; Benavente V; Pow-Sang ; Garrido G
    Prog Clin Biol Res; 1987; 243B():321-7. PubMed ID: 3659028
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Primary cryotherapy with salvage external beam radiotherapy for locally recurrent prostate cancer.
    Thomson AH; Kulkarni S; Bahl A
    Clin Oncol (R Coll Radiol); 2008 Jun; 20(5):385. PubMed ID: 18420393
    [No Abstract]   [Full Text] [Related]  

  • 20. More about prostate cancer--expectant management versus treatment.
    Anscher MS
    N C Med J; 1999; 60(6):313-4. PubMed ID: 10581934
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.